Net Medical Xpress Solutions, Inc. (NMXS)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 949 Thousand USD | -8.57% |
| 2022 | 1.03 Million USD | 22.12% |
| 2021 | 850 Thousand USD | 225.67% |
| 2020 | 261 Thousand USD | 177.66% |
| 2019 | 94 Thousand USD | 84.31% |
| 2018 | 51 Thousand USD | -25.0% |
| 2017 | 68 Thousand USD | 13.33% |
| 2016 | 60 Thousand USD | -14.29% |
| 2015 | 70 Thousand USD | -22.22% |
| 2014 | 90 Thousand USD | 32.35% |
| 2013 | 68 Thousand USD | 33.33% |
| 2012 | 51 Thousand USD | 168.42% |
| 2011 | 19 Thousand USD | 171.43% |
| 2010 | 7000.00 USD | -30.0% |
| 2009 | 10 Thousand USD | -87.95% |
| 2008 | 83 Thousand USD | 0.0% |
| 2007 | - USD | -100.0% |
| 2006 | 51 Thousand USD | -49.5% |
| 2005 | 101 Thousand USD | -63.41% |
| 2004 | 276 Thousand USD | 0.0% |
| 2003 | 276 Thousand USD | -3.83% |
| 2002 | 287 Thousand USD | -14.84% |
| 2001 | 337 Thousand USD | 810.81% |
| 2000 | 37 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 926 Thousand USD | -2.42% |
| 2023 Q2 | 964 Thousand USD | -3.41% |
| 2023 Q3 | 927 Thousand USD | -3.84% |
| 2023 Q1 | 998 Thousand USD | -3.85% |
| 2023 FY | 949 Thousand USD | -8.57% |
| 2023 Q4 | 949 Thousand USD | 2.37% |
| 2022 Q3 | 1 Million USD | 8.09% |
| 2022 Q4 | 1.03 Million USD | 3.59% |
| 2022 Q1 | 889 Thousand USD | 4.59% |
| 2022 Q2 | 927 Thousand USD | 4.27% |
| 2022 FY | 1.03 Million USD | 22.12% |
| 2021 FY | 850 Thousand USD | 225.67% |
| 2021 Q2 | 280 Thousand USD | -21.13% |
| 2021 Q3 | 776 Thousand USD | 177.14% |
| 2021 Q4 | 850 Thousand USD | 9.54% |
| 2021 Q1 | 355 Thousand USD | 0.0% |
| 2020 FY | 261 Thousand USD | 177.66% |
| 2019 FY | 94 Thousand USD | 84.31% |
| 2018 FY | 51 Thousand USD | -25.0% |
| 2018 Q1 | 67 Thousand USD | 0.0% |
| 2018 Q2 | 68 Thousand USD | 1.49% |
| 2017 Q3 | 68 Thousand USD | 13.33% |
| 2017 Q1 | 60 Thousand USD | 0.0% |
| 2017 Q2 | 60 Thousand USD | 0.0% |
| 2017 FY | 68 Thousand USD | 13.33% |
| 2016 Q3 | 70 Thousand USD | -2.78% |
| 2016 Q1 | 74 Thousand USD | 5.71% |
| 2016 Q4 | 60 Thousand USD | -14.29% |
| 2016 FY | 60 Thousand USD | -14.29% |
| 2016 Q2 | 72 Thousand USD | -2.7% |
| 2015 Q2 | 67 Thousand USD | -11.84% |
| 2015 Q3 | 66 Thousand USD | -1.49% |
| 2015 Q4 | 70 Thousand USD | 6.06% |
| 2015 Q1 | 76 Thousand USD | -15.56% |
| 2015 FY | 70 Thousand USD | -22.22% |
| 2014 Q3 | 71 Thousand USD | -1.39% |
| 2014 Q2 | 72 Thousand USD | 9.09% |
| 2014 Q1 | 66 Thousand USD | -2.94% |
| 2014 Q4 | 90 Thousand USD | 26.76% |
| 2014 FY | 90 Thousand USD | 32.35% |
| 2013 Q4 | 68 Thousand USD | 33.33% |
| 2013 FY | 68 Thousand USD | 33.33% |
| 2013 Q2 | 50 Thousand USD | 1566.67% |
| 2013 Q3 | 51 Thousand USD | 2.0% |
| 2013 Q1 | 3000.00 USD | -94.12% |
| 2012 Q2 | 146 Thousand USD | 873.33% |
| 2012 Q3 | 121 Thousand USD | -17.12% |
| 2012 FY | 51 Thousand USD | 168.42% |
| 2012 Q4 | 51 Thousand USD | -57.85% |
| 2012 Q1 | 15 Thousand USD | -21.05% |
| 2011 Q3 | 22 Thousand USD | -12.0% |
| 2011 Q1 | 21 Thousand USD | 200.0% |
| 2011 Q4 | 19 Thousand USD | -13.64% |
| 2011 FY | 19 Thousand USD | 171.43% |
| 2011 Q2 | 25 Thousand USD | 19.05% |
| 2010 Q2 | 3000.00 USD | -50.0% |
| 2010 Q3 | 1000.00 USD | -66.67% |
| 2010 Q4 | 7000.00 USD | 600.0% |
| 2010 FY | 7000.00 USD | -30.0% |
| 2010 Q1 | 6000.00 USD | -40.0% |
| 2009 Q2 | 60 Thousand USD | 130.77% |
| 2009 FY | 10 Thousand USD | -87.95% |
| 2009 Q1 | 26 Thousand USD | -68.67% |
| 2009 Q4 | 10 Thousand USD | -81.82% |
| 2009 Q3 | 55 Thousand USD | -8.33% |
| 2008 Q4 | 83 Thousand USD | 25.76% |
| 2008 FY | 83 Thousand USD | 0.0% |
| 2008 Q1 | 13 Thousand USD | 0.0% |
| 2008 Q2 | 11 Thousand USD | -15.38% |
| 2008 Q3 | 66 Thousand USD | 500.0% |
| 2007 Q3 | 10 Thousand USD | -61.54% |
| 2007 Q1 | 51 Thousand USD | 0.0% |
| 2007 FY | - USD | -100.0% |
| 2007 Q2 | 26 Thousand USD | -49.02% |
| 2007 Q4 | - USD | -100.0% |
| 2006 Q3 | 76 Thousand USD | 0.0% |
| 2006 FY | 51 Thousand USD | -49.5% |
| 2006 Q4 | 51 Thousand USD | -32.89% |
| 2006 Q1 | 101 Thousand USD | 0.0% |
| 2006 Q2 | 76 Thousand USD | -24.75% |
| 2005 Q1 | 201 Thousand USD | -27.17% |
| 2005 Q2 | 177 Thousand USD | -11.94% |
| 2005 FY | 101 Thousand USD | -63.41% |
| 2005 Q4 | 101 Thousand USD | -42.94% |
| 2005 Q3 | 177 Thousand USD | 0.0% |
| 2004 FY | 276 Thousand USD | 0.0% |
| 2004 Q4 | 276 Thousand USD | -22.47% |
| 2004 Q3 | 356 Thousand USD | 18.27% |
| 2004 Q2 | 301 Thousand USD | 9.06% |
| 2004 Q1 | 276 Thousand USD | 0.0% |
| 2003 Q4 | 276 Thousand USD | -8.0% |
| 2003 FY | 276 Thousand USD | -3.83% |
| 2003 Q1 | 312 Thousand USD | 8.71% |
| 2003 Q3 | 300 Thousand USD | 0.0% |
| 2003 Q2 | 300 Thousand USD | -3.85% |
| 2002 FY | 287 Thousand USD | -14.84% |
| 2002 Q1 | 337 Thousand USD | 0.0% |
| 2002 Q2 | 400 Thousand USD | 18.69% |
| 2002 Q4 | 287 Thousand USD | -18.0% |
| 2002 Q3 | 350 Thousand USD | -12.5% |
| 2001 Q3 | 340 Thousand USD | 0.89% |
| 2001 Q4 | 337 Thousand USD | -0.88% |
| 2001 FY | 337 Thousand USD | 810.81% |
| 2001 Q2 | 337 Thousand USD | -8.42% |
| 2001 Q1 | 368 Thousand USD | 0.0% |
| 2000 FY | 37 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Achiko AG | 2.55 Million USD | 62.885% |
| Accelera Innovations, Inc | - USD | -Infinity% |
| Aspyra Inc. | 3.6 Million USD | 73.663% |
| Cannabis Sativa, Inc. | 290.22 Thousand USD | -226.993% |
| CompuMed, Inc. | 392.97 Thousand USD | -141.491% |
| CompuGroup Medical SE & Co. KGaA | 846.5 Million USD | 99.888% |
| Cogstate Limited | 672.72 Thousand USD | -41.068% |
| CareView Communications, Inc. | 21.02 Million USD | 95.487% |
| Craneware plc | 35.37 Million USD | 97.317% |
| Caduceus Software Systems Corp. | 2.42 Million USD | 60.907% |
| Certive Solutions Inc. | 5.75 Million USD | 83.513% |
| Drug Free Solution, Inc. | - USD | -Infinity% |
| DATATRAK International, Inc. | 267.41 Thousand USD | -254.883% |
| Strainsforpains, Inc. | 1.93 Million USD | 50.905% |
| Healixa Inc. | 6.59 Million USD | 85.614% |
| Easy Technologies Inc. | - USD | -Infinity% |
| eWellness Healthcare Corporation | - USD | -Infinity% |
| Founders Bay Holdings | - USD | -Infinity% |
| Health Discovery Corporation | - USD | -Infinity% |
| Healthcare Integrated Technologies, Inc. | 635.2 Thousand USD | -49.4% |
| H-Source Holdings Ltd. | - USD | -Infinity% |
| InterCare DX, Inc. | 5062.89 USD | -18644.235% |
| iCoreConnect Inc. | 7.87 Million USD | 87.956% |
| IQ-AI Limited | - USD | -Infinity% |
| Cannabiz Mobile, Inc. | 494.05 Thousand USD | -92.085% |
| Mednow Inc. | 6 Million USD | 84.188% |
| Galileo Life Sciences, Inc. | 20 Thousand USD | -4645.0% |
| MediXall Group, Inc. | 2.82 Million USD | 66.359% |
| Mitesco, Inc. | 1.76 Million USD | 46.284% |
| MobileSmith, Inc. | 5.43 Million USD | 82.53% |
| NantHealth, Inc. | 267.4 Million USD | 99.645% |
| OneLife Technologies Corp. | - USD | -Infinity% |
| ORHub, Inc. | 8.53 Million USD | 88.887% |
| Patient Access Solutions, Inc. | 925.37 Thousand USD | -2.553% |
| Pharma-Bio Serv, Inc. | 346.5 Thousand USD | -173.875% |
| PPJ Healthcare Enterprises, Inc. | 2.59 Million USD | 63.402% |
| Medical Cannabis Payment Solutions, Inc. | 857.76 Thousand USD | -10.636% |
| Renalytix Plc | 8.53 Million USD | 88.881% |
| Revium Recovery Inc. | 1000.00 USD | -94800.0% |
| RYAH Group, Inc. | - USD | -Infinity% |
| Carepay Inc. | 27.55 Thousand USD | -3344.646% |
| Vaso Corporation | 2.06 Million USD | 53.932% |
| Vynleads, Inc. | 527.8 Thousand USD | -79.801% |